Holen Sie sich die Stockscreener-App
97.55
0.07%
-0.20
Schlusskurs vom Vortag:
$97.75
Offen:
$97.94
24-Stunden-Volumen:
76,541
Relative Volume:
0.30
Marktkapitalisierung:
$2.23B
Einnahmen:
$256.28M
Nettoeinkommen (Verlust:
$62.40M
KGV:
35.94
EPS:
2.7139
Netto-Cashflow:
$79.12M
1W Leistung:
-3.60%
1M Leistung:
-13.90%
6M Leistung:
+17.16%
1J Leistung:
+20.00%
1-Tages-Spanne:
$97.00
$99.77
1-Wochen-Bereich:
$97.00
$102.66
52-Wochen-Spanne:
$79.00
$118.01
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Firmenname
Lemaitre Vascular Inc
Sektor
Telefon
781-221-2266
Adresse
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
97.72 | 2.23B | 256.28M | 62.40M | 79.12M | 2.7139 |
ISRG
Intuitive Surgical Inc
|
439.40 | 155.16B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
148.30 | 40.68B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.52 | 33.06B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.05 | 31.30B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
208.46 | 30.18B | 5.54B | 1.52B | 1.74B | 10.37 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Fortgesetzt | Lake Street | Buy |
| 2024-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2024-04-26 | Hochstufung | Stifel | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Eingeleitet | Jefferies | Buy |
| 2021-02-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Hochstufung | Sidoti | Neutral → Buy |
| 2019-10-24 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Hochstufung | Lake Street | Hold → Buy |
| 2019-10-14 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Bestätigt | Barrington Research | Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Fortgesetzt | ROTH Capital | Buy |
| 2018-04-26 | Herabstufung | Stifel | Buy → Hold |
| 2018-04-26 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Eingeleitet | First Analysis Sec | Overweight |
| 2017-02-22 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-07-28 | Bestätigt | Barrington Research | Outperform |
| 2016-02-25 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
(LMAT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Thrivent Financial for Lutherans Grows Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Winners And Losers Of Q1: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & ConsumablesSpecialty Stocks - Yahoo Finance
LeMaitre Vascular to join two major healthcare investor conferences in June - Pluang
LeMaitre to Participate at Upcoming Investor Conferences in June - The Manila Times
LeMaitre schedules June talks at Jefferies and Goldman healthcare events - Stock Titan
GSA Capital Partners LLP Has $1.72 Million Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Three Healthcare Stocks Facing Potential Headwinds in 2026 - IndexBox
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $105 to $124 - Moomoo
Q3 2025 LeMaitre Vascular Inc Earnings Call Transcript - GuruFocus
Wakefield Asset Management LLLP Buys New Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
5 Insightful Analyst Questions From LeMaitre’s Q1 Earnings Call - Yahoo Finance
LeMaitre Vascular stock (US52567J1079): Q1 beat and raised 2026 guidance - AD HOC NEWS
[SCHEDULE 13G/A] LEMAITRE VASCULAR INC Amended Passive Investment Disclosure - Stock Titan
LeMaitre Vascular Senior Vice President of Operations Trent Kamke Sells 44% Of Holding - Moomoo
(LMAT) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Why LeMaitre Vascular (LMAT) Is Down 10.9% After Raising 2026 Guidance And Boosting Dividends - simplywall.st
Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Raises Target Price to $120 - 富途牛牛
Down 17.2% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround - Yahoo Finance
LeMaitre Vascular Inc (NASDAQ:LMAT): A Quality Investing Candidate Passing All Caviar Cruise Screen Tests - ChartMill
Insider Transaction: George LeMaitre Sells $5.03M Worth Of LeMaitre Vascular Shares - Benzinga
LeMaitre Vascular stock (US52567J1079): Insiders sell amid recent price drop - AD HOC NEWS
Vanguard Group Inc. Boosts Stake in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Lemaitre Vascular Insider Sold Shares Worth $5,032,413, According to a Recent SEC Filing - Moomoo
Insider Sell: Trent Kamke Sells Shares of LeMaitre Vascular Inc (LMAT) - GuruFocus
Lemaitre Vascular senior V.P. Kamke sells $313k in stock - Investing.com UK
Bridget Ross Sells 5,044 Shares of LeMaitre Vascular (NASDAQ:LMAT) Stock - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Insider Trent Kamke Sells 2,928 Shares - MarketBeat
LeMaitre Vascular CEO George LeMaitre sells $5.03m in stock By Investing.com - Investing.com Nigeria
LeMaitre Vascular CEO George LeMaitre sells $5.03m in stock - Investing.com
LeMaitre Vascular(LMAT.US) Officer Sells US$5.03 Million in Common Stock - Moomoo
LeMaitre Vascular (LMAT) CEO sells 46,481 shares, retains over 1.4M - Stock Titan
Lemaitre Vascular director Lawrence J Jasinski sells $433,730 in stock By Investing.com - Investing.com Australia
Lemaitre Vascular director Lawrence J Jasinski sells $433,730 in stock - Investing.com UK
Lemaitre Vascular senior V.P. Kamke sells $313k in stock By Investing.com - Investing.com Canada
LeMaitre (LMAT) senior VP sells 2,928 shares in open-market trade - Stock Titan
Lemaitre Vascular Insider Sold Shares Worth $433,730, According to a Recent SEC Filing - Moomoo
LeMaitre Vascular (LMAT) director exercises options and sells 5,044 shares - Stock Titan
LeMaitre Vascular (LMAT) director exercises options, then sells 3,943 shares - Stock Titan
LeMaitre outlines 2026 targets including $280M revenue and $3 EPS as international Artegraft expands - MSN
LMAT (NASDAQ) restricted stock vesting noted; Trent G. Kamke sold shares under Rule 144 - Stock Titan
Number of shareholders of LeMaitre Vascular, Inc. – NASDAQ:LMAT - TradingView
LeMaitre Vascular Is Maintained at Equal-Weight by Wells Fargo - Moomoo
LeMaitre to Present at the Bank of America Healthcare Conference - The Manila Times
LeMaitre management takes Bank of America conference stage May 13 - Stock Titan
LeMaitre Vascular declares $0.25 dividend - MSN
[144] LEMAITRE VASCULAR INC SEC Filing - Stock Titan
Proposed LMAT common-stock sale by Morgan Stanley (LMAT) reported 05/07/2026 - Stock Titan
Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lemaitre Vascular Inc-Aktie (LMAT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| LeMaitre George W | Chairman and CEO |
May 07 '26 |
Sale |
107.64 |
18,600 |
2,002,013 |
1,457,900 |
| Kamke Trent G | Senior V. P., Operations |
May 08 '26 |
Sale |
107.00 |
2,928 |
313,287 |
3,749 |
| Ross Bridget A | Director |
May 07 '26 |
Option Exercise |
48.15 |
5,044 |
242,882 |
8,986 |
| Ross Bridget A | Director |
May 07 '26 |
Sale |
111.10 |
5,044 |
560,366 |
3,942 |
| Jasinski Lawrence J | Director |
May 07 '26 |
Option Exercise |
65.92 |
2,858 |
188,412 |
8,657 |
| Jasinski Lawrence J | Director |
May 07 '26 |
Sale |
110.00 |
3,943 |
433,730 |
4,714 |
1.16%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):